- Fonkem E, Lok E, Robison D, Gautam S, Wong ET. The natural history of intravascular lymphomatosis. Cancer Med. 2014;3(4):1010–1024. doi:https://doi.org/10.1002/cam4.269.
- Fonkem E, Dayawansa S, Stroberg E, et al. Neurological presentations of intravascular lymphoma (IVL): meta-analysis if 654 patients. BMC Neurol. 2016;16(1):19. doi:https://doi.org/10.1186/s12883-015-0509-8.
- Magaki S, Gardner T, Khanlou N, Yong WH, Salamon N, Vinters HV. Brain biopsy in neurologic decline of unknown etiology. Hum Pathol. 2015;46(4):499–506. doi:https://doi.org/10.1016/j.humpath.2014.12.003.
- Chaturvedi S, Pant I, Kushwaha S, Jha DK. Intravascular lymphoma: an usual cause of rapid cognitive decline and the role of brain biopsy. BMJ Case Rep. 2014;2014:bcr2014205835. doi:https://doi.org/10.1136/bcr-2014-205835.
- Baumann TP, Hurwitz N, Karamitopolou-Diamantis E, Probst A, Herrmann R, Steck A. Diagnosis and treatment of intravascular lymphomatosis. Arch Neurol. 2000;57(3):374–377. doi:https://doi.org/10.1001/archneur.57.3.374.
- Ferreri AJ, Campo E, Ambrosetti A, et al. Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma. Ann Oncol. 2004;15(8):1215–1221. doi:https://doi.org/10.1093/annonc/mdh274.
- Nizamutdinov D, Patel NP, Huang JH, Fonkem E. Intravascular lymphoma in the CNS: options for treatment. Curr Treat Options Neurol. 2017;19(10):35. doi:https://doi.org/10.1007/s11940-017-0471-4.
- Kantarjian HM, O’Brien S, Smith TL, et al. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol. 2000;18(3):547–561. doi:https://doi.org/10.1200/JCO.2000.18.3.547.
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 34, 2021 - Issue 3